Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 33
- Uncategorized
CB21 Pharma Successfully Passes Certification Audit for Dronabinol Manufacturing
CB21 Pharma, a leading pharmaceutical company focused on developing and marketing innovative cannabinoid-based treatments, is pleased to announce the successful completion of its certification audit for manufacturing plant-derived Dronabinol by the State Institute for Drug Control (SÚKL).
- Uncategorized
Dalgety Doubles Down on UK-Grown Cannabis With Three New Strains and £8M Expansion Drive
Having done the legwork over the last five years to build a state-of-the-art 30,000sq ft indoor growing facility, and secure licencing to cultivate, manufacture and supply medical cannabis flower from its facility, Dalgety is wasting no time in ramping up its operations.
- Data & Analysis
Meta-Analysis Results Should ‘Redefine the Consensus Around Cannabis as a Medical Intervention’ for Cancer
The largest meta-analysis of scientific data on medical cannabis’ viability in cancer treatment to date has been published, finding overwhelmingly positive consensus for its therapeutic potential.
- CBD Market
Italy’s Hemp Industry Dealt 2nd Major Blow as CBD Oil Classified as Narcotic
Italy’s hemp industry has been dealt another major blow this week as the Regional Administrative Court (TAR) rejected an appeal, rendering CBD oil a narcotic.
- Uncategorized
New Hampshire Committee Recommends Rejection of Cannabis Legalization Bill, But Hope Remains for Full Senate Vote
New Hampshire’s Senate Judiciary Committee has voted to recommend against a bipartisan bill to legalize possession of cannabis for adults, but there is still hope for the bill in a full Senate floor vote.
- Uncategorized
Ananda Lists on US OTCQB Market, Argent Bio Signs Data Sharing Deal With AusCann, & IMC Under New Threat of NASDAQ Delisting
Ananda Pharma [stock_market_widget type=”chart” template=”line” assets=”ANANF” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Just days after welcoming the former Chief Operating Officer of GW and Jazz Pharmaceuticals to its ranks Ananda has announced its entrance onto the US OTCQB Exchange, opening up its stock to US investors.
- CBD Market
UK’s FSA Softens Stance on 0% THC in CBD Products, as MHRA Draws Clear Line on CBD Medical Claims
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the Food Standards Agency (FSA) have both issued regulatory updates on CBD this week.
- Uncategorized
Public Money May Have Helped Defeat Florida’s Cannabis Legalization Ballot
Florida Governor Ron Desantis and his wife are coming under increasing scrutiny over their apparent use of millions in public settlement funds to bankroll a critical anti-cannabis legalization campaign.
- Uncategorized
Cannabis Rescheduling ‘Delayed Not Dead’, Despite DEA’s Apathy
The US Cannabis Roundtable (USCR), one of the most influential advocacy groups in the country, is ‘still optimistic about the President acting on cannabis reform’.
- Press releases
Mamedica to Become ‘Official Licence Holder and Distributor’ of Cannabis Giant Cookies in the UK
Mamedica has today announced an exclusive partnership with Cookies to offer its premium pharmaceutical products to patients across the UK.
- Uncategorized
Israel’s 165% Tariffs on Canadian Cannabis Imports Approved by Ministry of Health
Israel has seemingly followed in the footsteps of its US ally this week after announcing plans to impose 165% tariffs on cannabis imports from Canada.
- Adult-Use
German Cannabis Law Remains Uncertain, Malta Imposes Controversial Changes, Dutch Cannabis Experiment Progresses, & More from Czech Republic
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
